Alexander Hardy
Chief Executive Officer at BIOMARIN PHARMACEUTICAL INC.
Net worth: 13 M $ as of 2024-03-30
Profile
Alexander Hardy is currently the President, Chief Executive Officer & Director at BioMarin Pharmaceutical, Inc. He is also a Director at Pharmaceutical Research & Manufacturers of America and a Member of The Wall Street Journal CEO Council.
Previously, he was the Chief Executive Officer & Director at Genentech, Inc. Hardy received his undergraduate degree from the University of Cambridge and his MBA from the Stephen M.
Ross School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-14 | 148,151 ( 0.08% ) | 13 M $ | 2024-03-30 |
Alexander Hardy active positions
| Companies | Position | Start |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Chief Executive Officer | 2023-11-30 |
| The Wall Street Journal CEO Council | Corporate Officer/Principal | - |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Director/Board Member | - |
Former positions of Alexander Hardy
| Companies | Position | End |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Chief Executive Officer | - |
Training of Alexander Hardy
| University of Cambridge | Undergraduate Degree |
| Stephen M. Ross School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| Private companies | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Health Technology |
| The Wall Street Journal CEO Council |
- Stock Market
- Insiders
- Alexander Hardy
